Shandong Weigao Group Medical Polymer Co (HKSE:01066) Gross-Profit-to-Asset % : 20.83% (As of Jun. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Shandong Weigao Group Medical Polymer Co's annualized Gross Profit for the quarter that ended in Jun. 2023 was HK$7,752 Mil. Shandong Weigao Group Medical Polymer Co's average Total Assets over the quarter that ended in Jun. 2023 was HK$37,210 Mil. Therefore, Shandong Weigao Group Medical Polymer Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 was 20.83%.

Shandong Weigao Group Medical Polymer Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co Gross-Profit-to-Asset % Chart

Shandong Weigao Group Medical Polymer Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

25.63

24.67

25.51

21.26

19.60

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															25.02	22.96	20.13	20.83	18.34

Competitive Comparison of Shandong Weigao Group Medical Polymer Co's Gross-Profit-to-Asset %

For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shandong Weigao Group Medical Polymer Co's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's Gross-Profit-to-Asset % falls into.

Shandong Weigao Group Medical Polymer Co Gross-Profit-to-Asset % Calculation

Shandong Weigao Group Medical Polymer Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2022 )	/	( (Total Assets (A: Dec. 2021 )	+	Total Assets (A: Dec. 2022 ))	/ count )
	=	7943.283	/	( (37441.466	+	37300.884)	/ 2 )
	=	7943.283	/	37371.175
	=	21.26 %

Shandong Weigao Group Medical Polymer Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	7751.576	/	( (37300.884	+	37118.239)	/ 2 )
	=	7751.576	/	37209.5615
	=	20.83 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Jun. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Shandong Weigao Group Medical Polymer Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (HKSE:01066) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

SHWGY:USA SHWGF:USA UK2:Germany

Address

No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN

Website

https://www.weigaogroup.com

Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Headlines

No Headlines